FLXS vs TSLA

FLXS exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a robust liquidity profile (Current Ratio 3.01). The stock is currently trading at a discount to its Graham Number of $52.49, suggesting a defensive margin of safety, while its PEG ratio of 0.93 indicates undervaluation relative to growth. Despite a negative YoY earnings growth figure, the company has consistently delivered massive earnings surprises over the last four quarters, signaling a strong operational recovery. The combination of low debt (D/E 0.31) and a low P/E relative to the sector average makes this a compelling value play in the consumer cyclical space.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.